Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome

Condition:   Cold Intervention:   Drug: Regan Tangjiang Sponsor:   Beijing Da-an Bio-technology Co., Ltd. Not yet recruiting - verified March 2017

Source: ClinicalTrials.gov - March 13, 2017 Category: Research Source Type: clinical trials